Skip to content

Telmisartan

Two telmisartan products sit on this shelf: Sartel, a 40 mg tablet listed for Hypertension and cardiovascular risk reduction, and Micardis HCT, which pairs telmisartan with hydrochlorothiazide.

Sartel

Hypertension, Cardiovascular Risk Reduction

40mg

Telmisartan tablets for high blood pressure and cardiovascular risk. It blocks a hormone that narrows blood vessels.

From$0.81/ tabletView

Micardis Hct

Hypertension

40mg + 12.5mg · 80mg + 12.5mg

Telmisartan and hydrochlorothiazide tablets for high blood pressure. One part relaxes blood vessels, the other removes extra fluid.

From$1.57/ tabletView

Key points

  • Telmisartan is an ARB that blocks angiotensin II at the AT1 receptor, relaxing blood vessels to lower pressure.
  • Micardis HCT adds 12.5 mg hydrochlorothiazide to telmisartan at 40 mg or 80 mg; Sartel is telmisartan alone at 40 mg.
  • Renin-angiotensin system medicines can cause fetal harm and alter kidney function and potassium levels.

Common questions about Telmisartan

Why does Micardis HCT pair telmisartan with hydrochlorothiazide?

Hydrochlorothiazide is a diuretic that reduces fluid volume, while telmisartan relaxes blood vessels by blocking angiotensin II. Together they lower blood pressure through two separate mechanisms, which can bring readings to target when telmisartan alone cannot. Micardis HCT is listed at 40 mg plus 12.5 mg and 80 mg plus 12.5 mg.

Which of these two products covers cardiovascular risk reduction?

Sartel is listed for both hypertension and Cardiovascular Risk Reduction. Micardis HCT is listed for hypertension only. If your prescriber has targeted cardiovascular risk alongside blood pressure, Sartel is the single-ingredient telmisartan option in this Heart & Blood Pressure catalogue.

Further reading